We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
President Bush's nomination of Andrew von Eschenbach to be the next FDA commissioner is at a stalemate as the agency and Sen. Chuck Grassley (R-Iowa) battle over access to an ongoing clinical trial investigation, an FDA source says. Read More
A new breast cancer study shows that switching to AstraZeneca’s Arimidex after several years of treatment with tamoxifen increases survival and reduces the chances of relapse by about half in postmenopausal women. Read More
The use of high doses of epoetin to treat anemia in patients with chronic kidney disease raises the risk for cardiovascular events, results from a new study caution. Read More
Painkiller Aleve may slightly increase the risk of heart attacks and strokes, a new study says, but researchers warn the results are not conclusive. Read More
A new breast cancer study shows that switching to AstraZeneca's Arimidex after several years of treatment with tamoxifen increases survival and reduces the chances of relapse by about half in postmenopausal women. Read More
More states are set to participate in Wal-Mart’s $4 prescription drug program as the company announced yet another expansion that will add 11 states and 17 prescription drugs to the plan.
HHS has notified Acambis that it would no longer consider the firm for a contract under the U.S. government’s modified vaccinia ankara (MVA) smallpox vaccine tender process.